Your prediction
Mindwalk Holdings Corp. Stock
Pros and Cons of Mindwalk Holdings Corp. in the next few years
Pros
Cons
News
MindWalk Applies HYFT® to Detect Functional Adjacency Risk in AI-Designed Therapeutics
AUSTIN, Texas – MindWalk Holdings Corp. (NASDAQ:HYFT) (“MindWalk” or the “Company”), a Bio-Native AI therapeutic research and technology company, today announced an application of its
MindWalk Validates Platform Precision with Breakthrough Discovery Targeting Pathogenic TDP-43 in Neurodegenerative Disease
14 January 2026 – VICTORIA, British Columbia – MindWalk Holdings Corp. (“MindWalk” or the “Company”) (Nasdaq: HYFT) today announced the discovery and validation of monoclonal antibodies and
MindWalk Advances Universal Influenza Program with a Breakthrough Functional Insight
Validated Across Influenza A and Influenza B, Including H3N2 Subclade K and Zoonotic Influenza A Subtypes H5, H7, H9
AUSTIN, Texas – January 9th, 2026 - MindWalk Holdings Corp.

